nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical profiles of newer class I antiarrhythmic agents—Tocainide, mexiletine, encainide, flecainide and lorcainide
|
Pottage, Anthony |
|
1983 |
52 |
6 |
p. C24-C31 nvt p. |
artikel |
2 |
Contents
|
|
|
1983 |
52 |
6 |
p. 1396-1408 13 p. |
artikel |
3 |
Definition of benign versus malignant ventricular arrhythmias: Targets for treatment
|
Bigger Jr., J.Thomas |
|
1983 |
52 |
6 |
p. C47-C54 nvt p. |
artikel |
4 |
Effect of antiarrhythmic drugs on mortality after myocardial infarction
|
Furberg, Curt D. |
|
1983 |
52 |
6 |
p. C32-C36 nvt p. |
artikel |
5 |
Hemodynamic effects of antiarrhythmic drugs
|
Block, Paul J. |
|
1983 |
52 |
6 |
p. C14-C23 nvt p. |
artikel |
6 |
Importance of metabolites in antiarrhythmic therapy
|
Woosley, Raymond L. |
|
1983 |
52 |
6 |
p. C3-C7 nvt p. |
artikel |
7 |
Introduction
|
Harrison, Donald C. |
|
1983 |
52 |
6 |
p. C1-C2 nvt p. |
artikel |
8 |
Methods for documenting antiarrhythmic efficacy
|
Harrison, Donald C. |
|
1983 |
52 |
6 |
p. C37-C40 nvt p. |
artikel |
9 |
Plasma level monitoring of antiarrhythmic drugs
|
Kates, Robert E. |
|
1983 |
52 |
6 |
p. C8-C13 nvt p. |
artikel |
10 |
Role of electrophysiologic techniques in the selection of antiarrhythmic drug regimens for ventricular arrhythmias
|
Ruskin, Jeremy N. |
|
1983 |
52 |
6 |
p. C41-C46 nvt p. |
artikel |
11 |
Treatment and prophylaxis of ventricular arrhythmias in acute myocardial infarction
|
Campbell, Ronald W.F. |
|
1983 |
52 |
6 |
p. C55-C59 nvt p. |
artikel |